结肠癌患者的瘤缩,全身炎症,身体组成和存活率之间的关系
Ross D Dolan1,2, Kathryn Pennel3, Joshua Thompson4
1Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK. Ross.Dolan@glasgow.ac.uk.
BJC reports
|February 5, 2025
概括
瘤缩与全身炎症反应 (SIR) 相关,影响癌症患者的身体组成和生存率. 需要进一步的研究来证实这种因果关系.
科学领域:
- 在瘤学瘤学.
- 炎症生物学 炎症生物学
- 身体构成研究 身体构成研究
背景情况:
- 瘤,瘤的环境和癌症缓解症中的系统性炎症之间的相互作用仍然不清楚.
- 这项研究调查了瘤特征和宿主炎症反应之间的复杂关系.
研究的目的:
- 检查瘤特征,全身炎症反应 (SIR),身体组成和癌症患者的生存率之间的关系.
- 阐明瘤缩和SIR在癌症缓解症中的作用.
主要方法:
- 评估了宿主特征,包括系统性炎症级 (SIG),肉症 (SMI) 和骨髓炎 (SMD).
- 使用千二测试分析了分类变量.
- 使用单变量和多变量考克斯回归进行了生存分析.
主要成果:
- 瘤缩与年龄相关,瘤阶段,边缘参与,SIG,SMI,SMD和5年生存率.
- 在T3癌症中,年龄,ASA等级和SIG独立与多变量分析的生存相关.
- 很大一部分患者 (57.7%) 的SIG分数为0或1.
结论:
- 瘤缩和随后的SIR可能会显著改变身体组成和患者的存活率.
- 需要进一步的临床前和临床研究来确定因果关系.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


